Table 1 Characteristics of adults who initiated HIV care between 2006 and 2017 in Jos, Nigeria
Patient characteristics | Period of enrollment | ||||
|---|---|---|---|---|---|
Total (N = 16,431) | 2006–2008 (N = 9357) | 2009–2011 (N = 3329) | 2012–2014 (N = 2449) | 2015–2017 (N = 1296) | |
Age, years, means (SD) | 35.1 (9.5) | 34.9 (9.3) | 34.8 (9.2) | 35.7 (9.9) | 35.9 (10.6) |
Age group, years, n (%) | |||||
< 30 | 5025 (30.6) | 2888 (30.86) | 1047 (31.5) | 723 (29.5) | 367 (28.3) |
30–39 | 6598 (40.2) | 3811 (40.73) | 1370 (41.2) | 931 (38.0) | 486 (37.5) |
≥ 40 | 4808 (29.3) | 2658 (28.4) | 912 (27.4) | 795 (32.5) | 443 (34.2) |
Sex, n (%) | |||||
Female | 10,788 (65.7) | 6263 (66.9) | 2173 (65.3) | 1,564 (63.9) | 788 (60.8) |
Male | 5643 (34.3) | 3094 (33.1) | 1156 (34.7) | 885 (36.1) | 508 (39.2) |
Risk for HIV | |||||
Heterosexual | 16,155 (98.3) | 9203 (98.4) | 3240 (97.3) | 2435 (99.4) | 1277 (98.5) |
Blood transfusion | 184 (1.1) | 139 (1.5) | 25 (0.8) | 14 (0.6) | 6 (0.5) |
Othersa | 92 (0.56) | 15 (0.2) | 64 (1.9) | 0 (0.0) | 13 (1.0) |
Baseline CD4, cells/mm3, mean (95% CI) | 221 (218–224) | 209 (206–213) | 243 (237–250) | 227 (218–235) | 235 (223–247) |
Baseline CD4, cells/mm3, mean (95% CI)b | 220 (117–223) | 210 (206–213) | 240(234–247) | 225 (216–233) | 231 (220–244) |
Baseline CD4-T-cell count, cells/mm3, n (%) | |||||
< 200 | 8393 (51.1) | 5126 (54.7) | 1549 (46.5) | 1150 (47.0) | 570 (44.0) |
200–349 | 3628 (22.1) | 2032 (21.7) | 776 (23.3) | 528 (21.6) | 292 (22.5) |
350–499 | 1550 (9.4) | 818 (8.7) | 361 (10.8) | 228 (9.3) | 143 (11.0) |
≥ 500 | 1213 (7.4) | 606 (6.5) | 316 (9.5) | 186 (7.6) | 105 (8.1) |
Missing | 1645 (10.0) | 775 (8.3) | 327 (9.8) | 357 (14.6) | 186 (14.4) |